Osaic Holdings
BDTX icon

Osaic Holdings’s Black Diamond Therapeutics BDTX Stock Holding History

Osaic Holdings’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.82K Sell
857
-3
-0.3% -$7 ﹤0.01% 7072
2025
Q4 		$2.09K Sell
860
-84
-9% -$297 ﹤0.01% 7079
2025
Q3 		$2.76K Buy
944
+660
+232% +$1.93K ﹤0.01% 7028
2025
Q2 		$704 Hold
284
– – ﹤0.01% 7270
2025
Q1 		$440 Buy
284
+200
+238% +$419 ﹤0.01% 7019
2024
Q4 		$179 Sell
84
-1,502
-95% -$4.3K ﹤0.01% 7179
2024
Q3 		$6.9K Sell
1,586
-643
-29% -$3.5K ﹤0.01% 6052
2024
Q2 		$10.4K Buy
2,229
+1,661
+292% +$8.92K ﹤0.01% 5766
2024
Q1 		$2.88K Hold
568
– – ﹤0.01% 6324
2023
Q4 		$1.59K Sell
568
-149
-21% -$350 ﹤0.01% 6609
2023
Q3 		$2.06K Sell
717
-1,767
-71% -$6.51K ﹤0.01% 6623
2023
Q2 		$11.8K Sell
2,484
-1,518
-38% -$3.1K ﹤0.01% 5880
2023
Q1 		$6.84K Buy
4,002
+1,220
+44% +$2.8K ﹤0.01% 6192
2022
Q4 		$5K Buy
2,782
+522
+23% +$940 ﹤0.01% 6263
2022
Q3 		$3K Hold
2,260
– – ﹤0.01% 6581
2022
Q2 		$5K Sell
2,260
-1,000
-31% -$2.33K ﹤0.01% 6447
2022
Q1 		$668K Sell
3,260
-127
-4% -$464 ﹤0.01% 2941
2021
Q4 		$18K Buy
3,387
+307
+10% +$2.15K ﹤0.01% 5852
2021
Q3 		$26K Sell
3,080
-200
-6% -$1.98K ﹤0.01% 5578
2021
Q2 		$41K Buy
3,280
+2,650
+421% +$52.4K ﹤0.01% 5181
2021
Q1 		$15K Buy
+630
New +$17K ﹤0.01% 5647

Other funds holding BDTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Osaic Holdings's BDTX Position: Q1 2026 in Review

Osaic Holdings reduced its Black Diamond Therapeutics (BDTX) stake by 0.35% in Q1 2026, selling an estimated $7 and leaving 857 shares worth $1.82K. The position accounts for ﹤0.01% of the portfolio, ranked #7072.

Osaic Holdings first reported a position in BDTX in Q1 2021 and has held it in 21 quarters since. The position peaked at $668K in Q1 2022. 104 funds tracked by Wall St. Rank hold BDTX as of Q1 2026.

  • Osaic Holdings held 857 shares of Black Diamond Therapeutics worth $1.82K as of Q1 2026.
  • Osaic Holdings sold 3 Black Diamond Therapeutics shares in Q1 2026, an estimated $7.
  • Black Diamond Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7072 holding.
  • Osaic Holdings first reported a position in Black Diamond Therapeutics in Q1 2021 and has held it in 21 quarters since.
  • Osaic Holdings's Black Diamond Therapeutics position peaked at $668K in Q1 2022.
  • 104 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.